Figure 2
From: EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Correlation analysis of the TCGA Breast Invasive carcinoma database (TCGA, Provisional 2012) using cBioPortal showed the correlation between ESR1 (ER)/PGR (PR)/ERBB2 (Her2) and FSCN1 mRNA levels.
